These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38801557)

  • 1. Integrative analysis indicates the potential values of ANKRD53 in stomach adenocarcinoma.
    Jin C; Lu X; Yang M; Hou S
    Discov Oncol; 2024 May; 15(1):188. PubMed ID: 38801557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
    Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
    Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
    Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
    PeerJ; 2024; 12():e16776. PubMed ID: 38274323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression of the
    Hu J; Xu J; Feng X; Li Y; Hua F; Xu G
    Front Cell Dev Biol; 2021; 9():700661. PubMed ID: 34631699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of expression signature and immune microenvironment signature of biomarker Endothelin Receptor Type A in stomach adenocarcinoma.
    Wang Z; Wang K; Yu X; Chen M; Du Y
    J Cancer; 2022; 13(7):2086-2104. PubMed ID: 35517422
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.
    Zou Q; Lv Y; Gan Z; Liao S; Liang Z
    Front Cell Dev Biol; 2021; 9():720649. PubMed ID: 34733840
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased
    Zhaoran S; Linnebacher CS; Linnebacher M
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 12. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
    Zhang X; Wang Y; A G; Qu C; Chen J
    Front Immunol; 2021; 12():721030. PubMed ID: 34531868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Phosphatase 1 Regulatory Subunit 3: A Prognostic Biomarker in Stomach Adenocarcinoma.
    Zhu YZ; Liao XW; Yin W; Wei HM
    Int J Gen Med; 2022; 15():1131-1146. PubMed ID: 35153505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
    Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
    Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ferroptosis-related gene in Helicobacter pylori infection, SOCS1, serves as a potential prognostic biomarker and corresponds with tumor immune infiltration in stomach adenocarcinoma: In silico approach.
    Yan P; Cheng M; Wang L; Zhao W
    Int Immunopharmacol; 2023 Jun; 119():110263. PubMed ID: 37156031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma.
    Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q
    Front Genet; 2022; 13():935056. PubMed ID: 36092903
    [No Abstract]   [Full Text] [Related]  

  • 19. High Expression of ERK-related RASGRF2 predicts Poor prognosis in patients with Stomach Adenocarcinoma and correlates with M2 macrophage.
    Du Y; Wang Z; Wan W
    J Cancer; 2021; 12(23):7177-7189. PubMed ID: 34729119
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
    Guo L; Liu D
    Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.